ALUVIA TABLET 200/50 MG

ALUVIA Tablet 200/50 mg is a fixed-dose antiretroviral medication containing Lopinavir 200 mg and Ritonavir 50 mg, widely used in the treatment and management of human immunodeficiency virus (HIV) infection. This combination belongs to the protease inhibitor class of antiretroviral drugs and is commonly prescribed as part of combination antiretroviral therapy (ART). Lopinavir inhibits the HIV protease enzyme required for viral replication, while ritonavir enhances the effectiveness of lopinavir by increasing its concentration in the bloodstream.

This pharmaceutical product helps reduce HIV viral load, improve immune system function, and slow the progression of HIV to AIDS when taken consistently under medical supervision. The ALUVIA Tablet 200/50 mg is recommended for adult and pediatric patients based on clinical guidelines and physician assessment.

 ALUVIA ensures safety, stability, and consistent therapeutic performance. The oral tablet formulation supports convenient administration and long-term treatment adherence. Although it does not cure HIV, this antiretroviral product plays a critical role in effective HIV management and supports improved quality of life when used as prescribed.

Product Features

• Contains a lopinavir 200 mg and Ritonavir 50 mg combination
• It belongs to the protease inhibitor class of antiretroviral drugs
• Used as part of a combination antiretroviral therapy (ART)
• Ritonavir boosts Lopinavir for enhanced antiviral action
• Helps control HIV replication and reduce viral load
• Manufactured under strict pharmaceutical quality standards

How It Helps

• Inhibits HIV protease enzyme to prevent viral replication
• Helps lower the HIV viral load in the bloodstream
• Supports immune system recovery and strength
• Slows the progression of HIV infection with regular use